| Entry |
|
|---|
| Name |
Anhydrous caffeine (JP15);
Caffeine (USP);
Anhydrous caffeine (TN) |
|---|
| Formula |
C8H10N4O2
|
|---|
| Mass |
194.0804 |
|---|
| Structure |
     |
|---|
| Source |
Coffea arabica [TAX:13443] |
|---|
| Target |
phosphodiesterase inhibitor [KO:K01120] [PATH:hsa00230];
adenosine A1 receptor antagonist [HSA:134] [PATH:hsa04080];
adenosine A2a receptor agonist [HSA:135] [PATH:hsa04020]
[PATH:hsa04080];
adenosine A2b receptor agonist [HSA:136] [PATH:hsa04020]
[PATH:hsa04080] |
|---|
| Metabolism |
CYP1A2 [HSA:1544], CYP2E1 [HSA:1571] |
|---|
| Activity |
Stimulant [central] |
|---|
| Remark |
Same as: C07481
Therapeutic category: 2115
ATC code: N06BC01
 |
|---|
| Comment |
Component of SG (TN), PL (TN), Ergotamine (TN), Cleamine (TN)
Xanthines |
|---|
| Other DBs |
CAS: 58-08-2
PubChem: 7847594
ChEBI: 27732
DrugBank: DB00201
PDB-CCD: CFF
LigandBox: D00528
NIKKAJI: J2.330B |
|---|
| KCF data |
 |
|---|
